Theravance Biopharma, Inc. (TBPH)
17.81
-0.31
(-1.71%)
USD |
NASDAQ |
Dec 09, 16:00
17.80
-0.01
(-0.06%)
After-Hours: 20:00
Theravance Biopharma Total Liabilities (Quarterly): 182.78M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | 52.61M |
| Skye Bioscience, Inc. | 8.488M |
| FibroGen, Inc. | 119.53M |
| Myomo, Inc. | 19.45M |
| VYNE Therapeutics, Inc. | 4.044M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 415.46M |
| Shareholders Equity (Quarterly) | 232.68M |
| Debt to Equity Ratio | 0.1917 |
| Current Ratio | 9.482 |
| Net Debt Paydown Yield | 0.06% |